What is COPD? Chronic Obstructive Pulmonary Disease is a progressive disease that constricts airways and dramatically hinders a person’s ability to breathe. It affects around 13% of Australians aged 40 or over. It causes mucus or blood-filled coughing‚ chest tightness and severe shortness of breath. The disease is comprised of Chronic Bronchitis‚ Asthma and Emphysema‚ with the seriousness of it being judged by four levels‚ each level increasing in severity. To this day‚ there is no known cure
Premium Asthma Chronic obstructive pulmonary disease Pneumonia
pulmonary disease (COPD) in England and Wales‚ carrying an economic cost of £491‚652‚000 per year. The NCCCC (2004) highlights an exacerbation of patient symptoms accounts for a substantial percentage of this cost‚ particularly those that result in hospitalisation‚ as identified by the Lung and Asthma Information Agency (2003) COPD is accountable for 90‚000 hospital admissions per year in the UK. This assignment will outline the anatomy and physiology of the respiratory system‚ define COPD‚ and highlight
Premium Respiratory physiology Pulmonology Respiratory system
Living With Asthma and COPD Jaclyn Carroll University of Phoenix Living With Asthma and COPD There are many things to take into consideration when diagnosing and treating asthma and COPD. They have many characteristics that can confuse one for the other and lead to the misdiagnosis and treatments that are associated with each respiratory disease. If one has never been faced with the reality of living with
Premium Asthma Chronic obstructive pulmonary disease
bronchi. The bronchioles then are a functional branch of the bronchi. The tiny pockets of alveoli store air briefly in order for oxygen to be absorbed in the bloodstream. Through the alveoli the gas exchange into the lungs occurs. Pathophysiology of COPD COPD stands for Chronic Obstructive Pulmonary Disease. It is typically caused by inhaled irritants such as tobacco smoke. It is a chronic inflammation of the airways‚ lung tissue‚ and pulmonary blood vessels. It limits air flow and is irreversible. The
Premium Asthma Respiratory system Heart
The use of inhaled corticosteroids in COPD In this study published in JAMA‚ the authors looked at eleven studies on the use of inhaled corticosteroids in patients with COPD defined as a smoking- related lung disease characterized by recurrent episodes of cough‚ sputum production and breathlessness (Drummond‚ 2407). The authors of this study did no research of their own‚ but instead looked at other double blind‚ randomized‚ placebo controlled studies from around the world‚ with a restriction that
Premium 3rd millennium Chronic obstructive pulmonary disease Asthma
COPD: Chronic Obstructive Pulmonary Disease Angelia Alleyne HCS/245 May 4‚ 2015 Professor Lori Olson COPD: Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease‚ or COPD‚ is a long-term disease that causes breathing problems. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD‚ however‚ is a heterogeneous collection of diseases with differing causes‚ pathogenic mechanisms‚ and physiological effects. Therefore a comprehensive approach
Premium Asthma Chronic obstructive pulmonary disease Pneumonia
Disease (COPD). This will be achieved by bringing the reader through the patients’ illness journey. The assignment will begin by defining COPD and briefly going through the pathophysiology and incidents of the condition. From there the reader will embark on the journey‚ starting with diagnosis. The author will attempt to give an in-depth exploration of the next stage‚ living for today while also discussing the Health Care Professionals’ role in providing a holistic approach to care. As COPD is a
Premium Management Marketing German language
References: 1 Global Strategy for the Diagnosis‚ Management and Prevention of COPD. (2013‚ February). Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Retrieved from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf 2 Hoyert‚ D.‚ & Xu‚ J. (2012). Deaths: Preliminary Data for 2011. Natl
Premium Asthma Chronic obstructive pulmonary disease
livings but is occasionally limited by his ill health.He used to be a heavy smoker .After realising the burden COPD has on general New Zealand population ‚affecting about15% of the adult population over the age of 45 years according to asthmanz( 2010) ‚l took this case study to gain in-depth understanding. Presenting hx Chari is a known patient with Chronic obstructive airway disease(COPD).He presented with increased shortness of breath‚ stabbing chest pain aggravated by breathing‚ continues coughing
Premium Asthma
Treatment for COPD Inhaled Therapies NICE COPD guidelines have made specific recommendations regarding the use of inhaled long-acting bronchodilators and inhaled steroids separately and in combination‚ but newer studies have assessed these drugs singly and in combination over longer periods of time. Bronchodilators (relievers) Short-acting beta2 agonists (SABA) Beta2 agonists act directly on bronchial smooth muscle to cause bronchodilation. They are the most widely used bronchodilators for COPD. Short-acting
Premium Chronic obstructive pulmonary disease Asthma